Browsing: Medication & Drugs

ESMO Asia 2024 united experts in the region as well as global experts to address Asia’s unique cancer challenges, featuring breakthroughs in immunotherapy, rare cancer networks, and patient-centred care.

From sunburn to altitude sickness, travel comes with unexpected risks. A well-stocked first aid kit ensures you’re ready for minor mishaps, letting you focus on enjoying your holiday. Here’s what to pack for safe, stress-free adventures wherever you go.

Novo Nordisk launches Wegovy in China, targeting the country’s 180 million people with obesity. Priced at ¥1,400 ($192 USD) per starter dose, it faces accessibility challenges as it’s not covered by national insurance. The move heightens competition with Eli Lilly.

Misusing antibiotics: stopping early, skipping doses, or treating viral infections can empower bacteria to resist drugs. Here’s how you can curb this crisis and ensure antibiotics remain effective for generations.

FDA has banned oral phenylephrine after finding it ineffective for nasal congestion. This decision affects well-known cold medicines and raises questions in Singapore, where 14 products with this ingredient remain approved. The Health Sciences Authority is reviewing the issue.

As men age, an benign prostatic hyperplasia (BPH) is common and can disrupt daily life. While not life-threatening, untreated BPH may lead to complications. Recognise symptoms early and explore treatment options, from lifestyle changes to minimally invasive procedures, to safeguard your prostate health.

Groundbreaking CD7 CAR-T therapy from NUS Medicine offers hope for T-cell acute lymphoblastic leukaemia (T-ALL) patients. Early case reports show 16 of 17 achieved remission, marking a significant cancer treatment advancement for relapsed/refractory T-ALL.

Three T-ALL patients – Viet Tai, Maria, and Hannah – share their inspiring cancer journeys through an innovative CD7 CAR-T therapy treatment, pioneered by researchers and clinicians from the NUS Medicine and NUHS and cultivated in-house by a modest laboratory in Singapore.

Pregnant women getting less than seven hours of sleep may risk their baby’s brain development, study suggests. Merck’s drug, tulisokibart, shows promise for ulcerative colitis, achieving remission in 26% of patients.

Pfizer is discontinuing its sickle cell disease treatment Oxbryta and withdrawing from markets approved due to risks of painful vaso-occlusive crisis and deaths seen in clinical trials, which found 8 deaths in those taking the drug vs 2 in placebo.